ThermiRase™ 2017-09-07T22:19:48+00:00

An Alternative to Botox®

If you have developed frown lines between your eyes, otherwise known as glabellar frown lines — or the dreaded eleven — and are looking to smooth the in-between-the-brow area, we have something new, an alternative to Botox®. It’s called ThermiRase™ and the results are longer lasting.

As we age, our skin loses elasticity. When we frown or squint or make facial expressions in response to our emotions, two major muscles, the corrugator and procerus, control the movement between our eyebrows. And although our muscles contract and relax, our skin doesn’t bounce back like it used to. In 2002, when the FDA approved the use of Botox®, this was generally the most effective way to smooth those frown lines. Until now.

ThermiRase™ or Radio-frequency (RF) nerve ablation, has been in use throughout other medical specialties such as cardiology, pain management, and dermatology for  years. Now the same technology is being employed to ablate certain nerves that control the muscle movement in between the eyes.

ThermiRase™ is a minimally invasive procedure performed in our office with local anesthesia, usually taking approximately 30 minutes. The skin is cleansed and disinfected. An aesthetic may be injected to minimize discomfort. Dr. Caruth will use the radio-frequency probe tip just under the skin and control low level energy impulses to stimulate and identify the nerves that cause the muscle to contract. Once the correct nerve is identified, a controlled radio frequency (RF) energy is administered to a portion of the nerve to disrupt its ability to contract the muscle related to the wrinkle.

Like Botox®, the ThermiRase™ procedure prevents the muscles from full function, and gives you a more relaxed and natural look. But unlike Botox®, which lasts about 2-4 months, ThermiRase™ results last longer. Our patients are seeing smooth results for 12-18 months. Individual results may vary.

Here is one of our patients before and after:

Want more information on this procedure? Check out our recent blog post.